adrenomedullin



adrenomedullin

Y1YY1R2RR2Q3QQ3S4SS4M5MM5N6NN6N7NN7F8FF8Q9QQ9G10GG10L11LL11R12RR12S13SS13F14FF14G15GG15C16CC16R17RR17F18FF18G19GG19T20TT20C21CC21T22TT22V23VV23Q24QQ24K25KK25L26LL26A27AA27H28HH28Q29QQ29I30II30Y31YY31Q32QQ32F33FF33T34TT34D35DD35K36KK36D37DD37K38KK38D39DD39N40NN40V41VV41A42AA42P43PP43R44RR44S45SS45K46KK46I47II47... and 5 more residue(s)...... and 5 more residue(s)

SMILES None
InChIKey None
Sequence YRQSMNNFQGLRSFGCRFGTCTVQKLAHQIYQFTDKDKDNVAPRSKISPQGY

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections


No bioactivity data available.

adrenomedullin

Y1YY1R2RR2Q3QQ3S4SS4M5MM5N6NN6N7NN7F8FF8Q9QQ9G10GG10L11LL11R12RR12S13SS13F14FF14G15GG15C16CC16R17RR17F18FF18G19GG19T20TT20C21CC21T22TT22V23VV23Q24QQ24K25KK25L26LL26A27AA27H28HH28Q29QQ29I30II30Y31YY31Q32QQ32F33FF33T34TT34D35DD35K36KK36D37DD37K38KK38D39DD39N40NN40V41VV41A42AA42P43PP43R44RR44S45SS45K46KK46I47II47... and 5 more residue(s)...... and 5 more residue(s)

Drug properties

Molecular type Peptide
Physiological/Surrogate Endogenous
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections


Compound is not listed as a drug.